Metabolic management of ischaemic heart disease

S. L. Chierchia, G. Fragasso

Research output: Contribution to journalArticle

Abstract

The present review summarizes the available information on the effects of the three major classes of antianginal agents (nitrates, calcium and beta-blockers) on myocardial energy metabolism. It also discusses the role of some new molecules (L-carnitine trimetazidine and ranolazine) that have been proposed as an alternative pharmacological approach for the metabolic management of cardiac ischaemic syndromes.

Original languageEnglish
Pages (from-to)2-5
Number of pages4
JournalEuropean Heart Journal
Volume14
Issue numberSUPPL. G
Publication statusPublished - 1993

    Fingerprint

Keywords

  • Antianginal drugs
  • Cardiac metabolism
  • Ischaemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this